CUAMC
TRAX

China Universal Asset Management Company’s First Tracks Biotherapeutics TRAX Stock Holding History

China Universal Asset Management Company’s Portfolio TRAX Stock Details TRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+5,553
New +$104K 0.01% 407

Other funds holding TRAX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
FEG
Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

China Universal Asset Management Company's TRAX Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in First Tracks Biotherapeutics (TRAX) in Q2 2026: 5,553 shares worth $112K. The stake represents 0.01% of the portfolio and ranks #407 among its holdings.

20 funds tracked by Wall St. Rank hold TRAX as of Q2 2026.

  • China Universal Asset Management Company held 5,553 shares of First Tracks Biotherapeutics worth $112K as of Q2 2026.
  • First Tracks Biotherapeutics was a new China Universal Asset Management Company position in Q2 2026.
  • First Tracks Biotherapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #407 holding.
  • 20 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.